Please login to the form below

Not currently logged in
Email:
Password:

Bone Therapeutics

This page shows the latest Bone Therapeutics news and features for those working in and with pharma, biotech and healthcare.

BioMimetic bone graft wins panel support

A US Food and Drug Administration committee has voted in support of BioMimetic Therapeutics' Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures. ... The US Food and Drug Administration's (FDA) Orthopaedic

Latest news

  • Malcolm's Market Eye: 7 to 13 July 2007

    Now a study in US publication Diabetes Care has suggested that Avandia could reduce bone mineral density in men. ... Northwest Therapeutics gets Swiss green light for brain cancer vaccine. Northwest Therapeutics saw its share price rise by 38p to 140p on

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Bone Therapeutics strengthens board with new chairman Bone Therapeutics strengthens board with new chairman

    Jean Stéphenne joins the cell therapy company from TiGenix. Belgian biotechnology company Bone Therapeutics has appointed Jean Stéphenne as its new chairman of the board of directors, succeeding Steve Swinson in ... Thomas Lienard, chief executive

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    He joins the Norwegian biotech from Bone Therapeutics. Zelluna Therapeutics has appointed its new chief executive officer in the form of Miguel Forte. ... Prior to his new role, Forte has held roles for Bone Therapeutics, TxCell, the European Medicines

  • Bone Therapeutics strengthens clinical development team Bone Therapeutics strengthens clinical development team

    Dr Miguel Forte joins the firm as chief medical officer. Dr Miguel Forte has joined Belgium biotechnology company Bone Therapeutics as its new chief medical officer. ... I look forward to working with the Bone Therapeutics team to realise the potential

  • Bone Therapeutics looks to Pfizer for clinical head Bone Therapeutics looks to Pfizer for clinical head

    Guy Heynen has 35 years of industry experience. Bone Therapeutics, the regenerative therapy company for bone diseases and orthopaedics, has named Guy Heynen as its chief clinical and regulatory officer. ... CEO of Bone Therapeutics Enrico Bastianello said

  • Wim Goemaere appointed CFO at Bone Therapeutics Wim Goemaere appointed CFO at Bone Therapeutics

    He joins from agricultural biotech firm Devgen. Bone Therapeutics yesterday announced that Wim Goemaere is to join the company as chief financial officer. ... Bone Therapeutics is also developing an allogeneic bone cell therapy product called allob.

More from appointments
Approximately 4 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics